Země: Nový Zéland
Jazyk: angličtina
Zdroj: Medsafe (Medicines Safety Authority)
Alprazolam 1mg (Exclusive of 1.5% excess.); ;
Upjohn New Zealand ULC
Alprazolam 1 mg (Exclusive of 1.5% excess.)
1 mg
Tablet
Active: Alprazolam 1mg (Exclusive of 1.5% excess.) Excipient: Colloidal silicon dioxide Erythrosine Indigo carmine Docusate sodium (85%) with sodium benzoate (15%) Lactose monohydrate Magnesium stearate Maize starch Microcrystalline cellulose
Blister pack, 50 tablets
Class C5 Controlled Drug
Class C5 Controlled Drug
Valdepharm
1. Anxiety states (anxiety neuroses). Symptoms which occur in such patients include anxiety, tension, fear, insomnia, apprehension, restlessness, concentration difficulties, irritability and/or autonomic hyperactivity resulting in a variety of somatic complaints. 2. Mixed anxiety-depression. Symptoms of both anxiety and depression occur concurrently in such patients. 3. Neurotic or reactive depression. Such patients primarily exhibit a depressed mood or a pervasive loss of interest or pleasure. Other characteristics include anxiety, appetite disturbances, changes in weight, cognitive disturbances, decreased energy, feeling of worthlessness or guilt, insomnia, somatic complaints, or thoughts of death or suicide. 4. Anxiety states, mixed anxiety-depression, or neurotic depression associated with other diseases such as the chronic phase of alcohol withdrawal and functional or organic disease, particularly certain gastrointestinal, cardiovascular, or dermatological disorders.
Package - Contents - Shelf Life: Blister pack, - 50 tablets - 36 months from date of manufacture stored at or below 25°C - Blister pack, - 100 tablets - 36 months from date of manufacture stored at or below 25°C
1984-08-29
XANAX ® 1 XANAX ® TABLETS _Alprazolam_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Xanax. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Xanax against the benefits this medicine is expected to have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH YOUR MEDICINE. You may need to read it again. WHAT XANAX IS USED FOR Xanax is used to treat anxiety. Anxiety or tension associated with the normal stress of everyday life usually does not require treatment with medicines. Xanax is also used to treat panic attacks. Ask your doctor if you have any questions about why this medicine has been prescribed for you. Your doctor may have prescribed Xanax for another purpose. Xanax belongs to a group of medicines called benzodiazepines. They are thought to work by their action on brain chemicals. IF YOU TAKE XANAX FOR TOO LONG, IT MAY BECOME HABIT-FORMING. BENZODIAZEPINES MAY LEAD TO PHYSICAL OR PSYCHOLOGICAL DEPENDENCE. IF YOU HAVE ANY CONCERNS, YOU SHOULD DISCUSS THIS WITH YOUR DOCTOR. This medicine is available only with a doctor's prescription. BEFORE YOU TAKE XANAX _WHEN YOU MUST NOT TAKE IT_ DO NOT TAKE XANAX IF YOU HAVE AN ALLERGY TO: any medicine containing alprazolam any of the ingredients listed at the end of this leaflet any other medicine in the benzodiazepine group. Some of the symptoms of an allergic reaction may include: shortness of breath wheezing or difficulty breathing swelling of the face, lips, tongue or other parts of the body rash, itching or hives on the skin. DO NOT TAKE XANAX IF YOU HAVE OR HAVE HAD ANY OF THE FOLLOWING MEDICAL CONDITIONS: myasthenia gravis which causes severe muscle weakness severe and chronic lung disease. DO NOT TAKE THIS MEDICINE IF YOU ARE PREGNANT. It may affect your Přečtěte si celý dokument
Version:pfdxanat10119 Supersedes: pfdxanat11018 Page 1 of 12 NEW ZEALAND DATA SHEET 1. PRODUCT NAME XANAX ® 0.25 mg, 0.5 mg and 1.0 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 0.25 mg tablet contains 0.25 mg alprazolam Each 0.5 mg tablet contains 0.5 mg alprazolam Each 1.0 mg tablet contains 1.0 mg alprazolam Excipients with known effects: Lactose monohydrate Sodium benzoate For the full list of excipients, see section 6.1 List of excipients. 3. PHARMACEUTICAL FORM XANAX 0.25mg tablets are white, scored, ovoid shaped tablets coded "Upjohn 29". Length 9.1 mm, Width 5.5 mm, Thickness 3.5 mm. XANAX 0.5mg tablets are pink coloured, scored, ovoid shaped tablets coded "Upjohn 55". Length 9.1 mm, Width 5.5 mm, Thickness 3.5 mm. XANAX 1.0mg tablets are lavender coloured, scored, ovoid shaped tablets coded "Upjohn 90". Length 9.1 mm, Width 5.5 mm, Thickness 3.5 mm. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS XANAX (alprazolam) is indicated for the treatment of: 1. ANXIETY STATES (ANXIETY NEUROSES). Symptoms which occur in such patients include anxiety, tension, fear, insomnia, apprehension, restlessness, concentration difficulties, irritability and/or autonomic hyperactivity resulting in a variety of somatic complaints. 2. MIXED ANXIETY-DEPRESSION. Symptoms of both anxiety and depression occur concurrently in such patients. Version:pfdxanat10119 Supersedes: pfdxanat11018 Page 2 of 12 3. NEUROTIC OR REACTIVE DEPRESSION. Such patients primarily exhibit a depressed mood or a pervasive loss of interest or pleasure. Other characteristics include anxiety, appetite disturbances, changes in weight, cognitive disturbances, decreased energy, feeling of worthlessness or guilt, insomnia, somatic complaints, or thoughts of death or suicide. 4. ANXIETY STATES, MIXED ANXIETY-DEPRESSION, OR NEUROTIC DEPRESSION associated with other diseases such as the chronic phase of alcohol withdrawal and functional or organic disease, particularly certain gastrointestinal, cardiovascular, or dermatological disorders. Přečtěte si celý dokument